Richmond, VA, United States of America

Bruce E Tomczuk

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent. Top assignee: A. H. Robins Company, Incorporated. Active years: 1988-1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bruce E Tomczuk. Retrieved from https://idiyas.com/inventor/bruce-e-tomczuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 2.2

ph-index = 1

Forward Citations = 9(Granted Patents)


Location History:

  • Richmond, VA (US) (1988 - 1990)
  • Fairport, NY (US) (1991 - 1992)

Company Filing History:


Years Active: 1988-1992

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Bruce E. Tomczuk

Introduction

Bruce E. Tomczuk, an accomplished inventor based in Richmond, Virginia (US), has made significant contributions to the field of therapeutic agents with a focus on novel pyrazole derivatives. With a total of seven patents to his name, Tomczuk's work exemplifies the spirit of innovation and dedication to enhancing health outcomes.

Latest Patents

Among his notable inventions are two recent patents that showcase his expertise in medicinal chemistry. The first patent is for 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives. This innovative compound is structured as follows: where X can be hydrogen or a halogen, hydroxy, C1 -C4 alkyl, or C1 -C4 alkoxy; Y can also be hydrogen or a halogen, C1 -C4 alkyl, or C1 -C4 alkoxy; and Z can take the form of hydroxy, C1 -C4 alkoxy, or an amine substituent. These compounds are identified as potential therapeutic agents exhibiting anxiolytic, anticonvulsant, and muscle relaxant effects in warm-blooded animals, thereby targeting significant medical needs.

Furthermore, his second patent features 3-amino-5-arylpyrazole-4-acetic acid derivatives. This invention introduces new pyrazole-4-acetic acid derivatives that have broad utility as therapeutic agents, demonstrating similar anxiolytic, anticonvulsant, and muscle relaxant properties. An illustrative example of this compound is 3-(dimethylamino)-5-(4-methylphenyl)-1H-pyrazole-4-acetamide.

Career Highlights

Bruce E. Tomczuk is currently affiliated with the A. H. Robins Company, Incorporated, where he applies his expertise in pharmaceutical innovation. His work in developing therapeutics reflects his commitment to improving health outcomes and demonstrates his proficiency in the realm of drug development.

Collaborations

Throughout his career, Tomczuk has collaborated with notable coworkers such as Deborah S. Sutherland and Chandler R. Taylor Jr. These partnerships have played a pivotal role in advancing his research and patent portfolio, enriching the collaborative environment at A. H. Robins Company.

Conclusion

In summary, Bruce E. Tomczuk's contributions to the field of medicinal chemistry through his innovative patents underscore his role as a key inventor in creating therapeutic agents. His work not only enhances the understanding of pyrazole derivatives but also serves as a foundation for future advancements in the treatment of anxiety and related conditions. As he continues to build upon his patents, Tomczuk remains a notable figure in the landscape of pharmaceutical innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…